首页> 外国专利> Selective inhibitors of nuclear factor-kappaB activation and uses thereof

Selective inhibitors of nuclear factor-kappaB activation and uses thereof

机译:核因子-κB活化的选择性抑制剂及其用途

摘要

The present invention provides cell permeable NF-κB inhibitors consist of a polypeptide derived from the p65 subunit of NF-κB and a protein transduction domain derived from antennapedia third helix sequence. The inhibitor suppressed NF-κB activation induced by TNF, LPS, IL-1, okadaic acid, PMA, H2O2 and cigarette smoke condensate. NF-κB-regulated reporter gene expression induced by TNF, TNFR1, TRADD, TRAF2, NIK, IKK and p65 was suppressed by the inhibitor. The inhibitor enhanced TNF- and chemotherapeutic agent-induced apoptosis. Overall these results demonstrate a NF-κB inhibitor that can selectively inhibit NF-κB activation induced by various inflammatory stimuli, downregulate NF-κB mediated gene expression and upregulate apoptosis.
机译:本发明提供细胞可渗透的NF-κB抑制剂,其由衍生自NF-κB的p65亚基的多肽和衍生自触足第三螺旋序列的蛋白质转导域组成。该抑制剂抑制了TNF,LPS,IL-1,冈田酸,PMA,H 2 O 2 和香烟烟雾冷凝物诱导的NF-κB活化。抑制剂抑制了TNF,TNFR1,TRADD,TRAF2,NIK,IKK和p65诱导的NF-κB调控的报告基因表达。该抑制剂可增强TNF和化疗药物诱导的细胞凋亡。总的来说,这些结果表明NF-κB抑制剂可以选择性地抑制由各种炎性刺激诱导的NF-κB活化,下调NF-κB介导的基因表达并上调凋亡。

著录项

  • 公开/公告号US2005201976A1

    专利类型

  • 公开/公告日2005-09-15

    原文格式PDF

  • 申请/专利权人 BHARAT B. AGGARWAL;SUJAY SINGH;

    申请/专利号US20040981082

  • 发明设计人 BHARAT B. AGGARWAL;SUJAY SINGH;

    申请日2004-11-04

  • 分类号A61K38/19;A61K31/704;C07K14/52;C07H21/04;A61K33/24;

  • 国家 US

  • 入库时间 2022-08-21 22:25:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号